AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 289: H975-H976, 2005; doi:10.1152/ajpheart.00421.2005
0363-6135/05 $8.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keller, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keller, B. B.

EDITORIAL FOCUS

Developmental structure-function insights from Tbx5del/+ mouse model of Holt-Oram syndrome

Bradley B. Keller

Division of Pediatric Cardiology, Heart Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania

IN THIS ISSUE of the American Journal of Physiology-Heart and Circulatory Physiology, Zhou et al. (32) describe impaired diastolic ventricular function measured by high-resolution (30 MHz) ultrasound and evidence for atrial septal defect (ASD) based on in vivo ultrasound and postmortem magnetic resonance imaging and anatomic examination in a Tbx5del/+ mouse model for Holt-Oram syndrome. Tbx5del/+ mice and control littermates were studied at 1, 2, 4, and 8 wk of age. A significant correlation between left ventricular Tbx5 gene expression and left ventricular diastolic dysfunction and right ventricular dilation was noted at 2 wk of age. This innovative study highlights several important issues related to the search for primary mechanisms for congenital cardiovascular (CV) malformations, the dynamic relationship structure and function during CV morphogenesis, and the correlation of data derived from targeted genetic animal models with clinical syndromes.

This study serves as an excellent example of the value of a combined analysis of both cardiac function and structure in evaluating CV phenotype in targeted genetic animal models of congenital heart disease. The goal of defining the primary mechanisms responsible for congenital CV malformations has been a driving force in CV research for over one hundred years (25). Major advances in our understanding of CV morphogenesis have occurred based on improved imaging and morphometric techniques (1, 14, 22, 27–29), the careful analysis of fate maps (24), ablation and chimera experiments (12), and the analysis of explant cell-cell and cell-matrix interactions (6), to name only a few key developments. Many of the genetic cascades that regulate normal CV morphogenesis have been identified over the past 20 years, leading to the generation of numerous targeted genetic animals, primarily mice, zebra fish, and frogs, that are useful in identifying and confirming these developmental mechanisms (7, 16, 30).

Animal models that target specific genetic cascades have become standard reagents in the investigation of development and disease. One of the challenges in targeting the key genes and proteins involved in CV morphogenesis is the tendency for lethal phenotype in homozygous deficient animals and for subtle or absent phenotypes in heterozygous animals. The subtle phenotypes of heterozygous animals, as in the Tbx5del/+ mouse model for Holt-Oram syndrome (5), are most likely to provide insights into human malformations (4). For example, the haplotype deletion Nkx2.5del/+ mouse recapitulates the ASD and conduction defects noted in humans with Nkx2.5 mutations (10, 17, 20). In the current study, it is important to note that although all 12 Tbx5del/+ mice were found to have left ventricular diastolic dysfunction and altered Tbx5 gene expression, only 8 of 12 mice were noted to have ASDs by direct inspection. These findings are consistent with the variable cardiac phenotype of patients with Holt-Oram syndrome, where ASD was found in 60.8% of patients and more complex congenital cardiac defects were found in 17.5% (23).

To date there is no correlation between Tbx5 genotype and phenotype in Holt-Oram syndrome patients (3, 15), and Tbx5 mutations have also been noted in patients with congenital heart disease independent of Holt-Oram syndrome (19). Developmental studies show a uniform Tbx5 gene expression throughout the developing myocardium (13), with later restriction to posterior sinoatrial segments of the heart. In the current study (32), left ventricular Tbx5 gene expression correlated with measures of altered ventricular diastolic function in Tbx5del/+ mice. Thus it is possible that there are more subtle changes in ventricular structure and function in patients with Holt-Oram syndrome that will be shown to correlate with genotype.

Understanding the genotype-phenotype variations in clinical populations and in targeted genetic animals requires recognition of the dynamic adaptation that occurs between genetic cascades and CV structure and function in the embryo and fetus. The quantitative measurement of CV function during the period of primary cardiac morphogenesis has rapidly progressed to include the characterization of CV function in a wide range of species (fly, fish, frog, chick, rat, mouse, and human) from shortly after the onset of cardiac activity through the completion of gestation. For the mouse embryo, quantitative measures include the invasive measurement of blood pressure, blood velocity, and chamber dimensions as well as the increasing availability of noninvasive measures to define both embryonic function and structure (see, e.g., Refs. 8, 11, 18, 31). Relevant to the current data described by Zhou et al. (32), primary changes in ventricular filling characteristics (9, 26) can generate permanent changes in CV structure and function that include both obvious changes in ventricular phenotype (21) and subtle changes in myofiber architecture (27). Thus the current study provides data to suggest that the primary event in this model is altered ventricular Tbx5 gene expression that results in left ventricular diastolic dysfunction and raises the possibility that changes in atrial septal morphogenesis (2), as well as flow-mediated changes in tricuspid valve diameter and right ventricular dimensions, may be secondary events.

The current study by Zhou et al. (32) validates the utility of chamber-specific, quantitative, high-resolution echocardiographic imaging in characterizing the primary and secondary changes in CV structure and function present in the Tbx5del/+ mouse model of Holt-Oram syndrome. The underlying mechanisms by which temporally and spatially specific reductions in myocardial Tbx5 expression during embryogenesis alter CV structure, function, adaptation, and final CV phenotype are yet to be identified.

FOOTNOTES


Address for correspondence: B. B. Keller, Div. of Pediatric Cardiology, Children's Hospital of Pittsburgh, 3705 Fifth Ave., Pittsburgh, PA 15213 (E-mail: Bradley.Keller{at}chp.edu)

REFERENCES

  1. Anderson RH, Webb S, and Brown NA. Clinical anatomy of the atrial septum with reference to its developmental components. Clin Anat 12: 362–374, 1999.[CrossRef][Medline]
  2. Atkins DL, Clark EB, and Marvin WJ Jr. Foramen ovale/atrial septum area ratio: a marker of transatrial blood flow. Circulation 66: 281–283, 1982.[Abstract/Free Full Text]
  3. Bassington AM, Sung SS, Toydemir RM, Le T, Roeder AD, Rutherford AE, Whitby FG, Jorde LB, and Bamshad MJ. Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype. Am J Hum Genet 73: 74–85, 2003.[CrossRef][Web of Science][Medline]
  4. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J, Grayzel D, Kroumpouzou E, Traill TA, Leblanc-Straceski J, Renault B, Kucherlapati R, Seidman JG, and Seidman CE. Mutations in human TBX5 cause limb and cardiac malformations in Holt-Oram syndrome. Nat Genet 15: 30–35, 1997.[CrossRef][Web of Science][Medline]
  5. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitalle L, Caron S, Conner DA, Gessler M, Nemer M, Seidman CE, and Seidman JG. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106: 709–721, 2001.[CrossRef][Web of Science][Medline]
  6. Eisenberg LM and Markwald RR. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 77: 1–6, 1995.[Free Full Text]
  7. Farrell MJ and Kirby ML. Cell biology of cardiac development. Int Rev Cytol 202: 99–158, 2001.[Web of Science][Medline]
  8. Gui YH, Linask KK, Khowsathit P, and Huhta JC. Doppler echocardiography of normal and abnormal embryonic mouse heart. Pediatr Res 40: 633–642, 1996.[Web of Science][Medline]
  9. Hogers B, DeRuiter MC, Gittenberger-de Groot AC, and Poelmann RE. Unilateral vitelline vein ligation alters intracardiac blood flow patterns and morphogenesis in the chick embryo. Circ Res 80: 473–481, 1997.[Abstract/Free Full Text]
  10. Jay PY, Harris BS, Maguire CT, Buerger A, Wakimoto H, Tanaka M, Kupershmidt S, Roden DM, Schultheiss TM, O'Brien TX, Gourdie RG, Berul CI, and Izumo S. Nkx2–5 mutation causes anatomic hypoplasia of the cardiac conduction system. J Clin Invest 113: 1130–1137, 2004.[CrossRef][Web of Science][Medline]
  11. Keller BB, MacLennan MJ, Tinney JP, and Yoshigi M. In vivo assessment of embryonic cardiovascular dimensions and function in day-10.5 to -14.5 mouse embryos. Circ Res 79: 247–255, 1996.[Abstract/Free Full Text]
  12. Kirby ML, Turnage KL III, and Hays BM. Characterization of conotruncal malformations following ablation of "cardiac" neural crest. Anat Rec 213: 87–93, 1985.[CrossRef][Medline]
  13. Liberatore CM, Searcy-Schrick RD, and Yutzey KE. Ventricular expression of tbx5 inhibits normal heart chamber development. Dev Biol 223: 169–180, 2000.[CrossRef][Web of Science][Medline]
  14. Molin DG, DeRuiter MC, Wisse LJ, Azhar M, Doetschman T, Poelmann RE, and Gittenberger-de Groot AC. Altered apoptosis pattern during pharyngeal arch artery remodelling is associated with aortic arch malformations in Tfg{beta}2 knock-out mice. Cardiovasc Res 56: 312–322, 2002.[Abstract/Free Full Text]
  15. Mori AD and Bruneau BG. TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr Opin Cardiol 19: 211–215, 2004.[CrossRef][Web of Science][Medline]
  16. Olsen EN. A decade of discoveries in cardiac biology. Nat Med 10: 467–474, 2004.[CrossRef][Web of Science][Medline]
  17. Pashmforoush M, Lu JT, Chen H, Amand TS, Kondo R, Pradervand S, Evans SM, Clark B, Feramisco JR, Giles W, Ho SY, Benson DW, Silberbach M, Shou W, and Chien KR. Nkx2–5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and congenital heart block. Cell 117: 373–386, 2004.[CrossRef][Web of Science][Medline]
  18. Phoon CK and Turnbull DH. Ultrasound biomicroscopy-Doppler in mouse cardiovascular development. Physiol Genomics 14: 3–15, 2003.[Abstract/Free Full Text]
  19. Reamon-Buettner SM and Borlak J. TBX5 mutations in non-Holt-Oram syndrome (HOS) malformed hearts. Hum Mutat 24: 104, 2004.[Medline]
  20. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP, Maron BJ, Seidman CE, and Seidman JG. Congenital heart disease caused by mutations in the transcription factor NKX2–5. Science 281 :108–111, 1998.[Abstract/Free Full Text]
  21. Sedmera D, Pexieder T, Rychterova V, Hu N, and Clark EB. Remodeling of chick embryonic ventricular myoarchitecture under experimentally changed loading conditions. Anat Rec 254: 238–252, 1999.[CrossRef][Medline]
  22. Sedmera D, Pexieder T, Vuillemin M, Thompson RP, and Anderson RH. Developmental patterning of the myocardium. Anat Rec 258: 319–337, 2000.[CrossRef][Medline]
  23. Sletten LJ and Pierpont ME. Variation in severity of cardiac disease in Holt-Oram syndrome. Am J Med Genet 65: 128–132, 1996.[CrossRef][Web of Science][Medline]
  24. Stanier DY, Lee RK, and Fishman MC. Cardovascular development in the zebrafish. I. Myocardial fate map and heart tube formation. Development 119: 31–40, 1993.[Abstract]
  25. Taussig HB. Evolutionary origin of cardiac malformations. J Am Coll Cardiol 12: 1079–1086, 1988.[Abstract]
  26. Tobita K and Keller BB. Right and left ventricular wall deformation patterns in normal and left heart hypoplasia chick embryos. Am J Physiol Heart Circ Physiol 279: H959–H969, 2000.[Abstract/Free Full Text]
  27. Tobita K, Garrison JB, Liu LJ, Tinney JP, and Keller BB. Three-dimensional myofiber architecture of the embryonic left ventricle during normal development and altered mechanical loads. Anat Rec A Discov Mol Cell Evol Biol 283: 193–201, 2005.[Medline]
  28. Van Mierop LH, Alley RD, Kausel HW, and Stranahan A. The anatomy and embryology of endocardial cushion defects. J Thorac Cardiovasc Surg 43: 71–83, 1962.[Web of Science][Medline]
  29. Van Praagh R. Diagnosis of complex congenital heart disease: morphologic-anatomic method and terminology. Cardiovasc Intervent Radiol 7: 115–120, 1984.[Medline]
  30. Yelon D. Cardiac patterning and morphogenesis in zebrafish. Dev Dyn 222: 552–563, 2001.[CrossRef][Web of Science][Medline]
  31. Zhou YQ, Foster FS, Qu DW, Zhang M, Harasiewicz KA, and Adamson SL. Applications for multifrequency ultrasound biomicroscopy in mice from implantation to adulthood. Physiol Genomics 10: 113–126, 2002.[Abstract/Free Full Text]
  32. Zhou Y-Q, Zhu Y, Bishop J, Davidson L, Henkelman RM, Bruneau BG, and Foster FS. Abnormal cardiac inflow patterns during postnatal development in mouse model of Holt-Oram syndrome. Am J Physiol Heart Circ Physiol 289: H992–H1001, 2005.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keller, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keller, B. B.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.